The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dumas Jacques since year 2005.
The trader's CIK number is 1598640.
At the time of this reporting, Dumas Jacques is the Chief ScientificOfficer of Tetraphase Pharmaceuticals Inc .
(stock ticker symbol TTPH).
See this page for all insider trading activities at Tetraphase Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-30||TTPH||Tetraphase Pharmaceuticals Inc||Option Ex||8,750||3.69||32,287|
|2018-01-30||TTPH||Tetraphase Pharmaceuticals Inc||Sale||8,750||6.22||54,425|
|2018-01-09||TTPH||Tetraphase Pharmaceuticals Inc||Sale||7,167||6.21||44,507|
|2017-10-31||TTPH||Tetraphase Pharmaceuticals Inc||Sale||8,750||6.03||52,762|
|2017-10-31||TTPH||Tetraphase Pharmaceuticals Inc||Option Ex||8,750||3.69||32,287|
|2017-08-22||TTPH||Tetraphase Pharmaceuticals Inc||Sale||17,500||6.00||105,000|
|2017-08-22||TTPH||Tetraphase Pharmaceuticals Inc||Option Ex||17,500||3.69||64,575|
|2017-08-17||TTPH||Tetraphase Pharmaceuticals Inc||Sale||7,155||5.86||41,928|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dumas Jacques (Chief ScientificOfficer of Tetraphase Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.